Alvotech and Fuji Pharma have agreed to extend their existing exclusive strategic partnership in Fuji Pharma’s native Japan, adding a further four biosimilar products, while discussions between the firms “continue over additional biosimilar candidates.”
Alvotech And Fuji Pharma Broaden Biosimilar Alliance In Japan
Number Of New Candidates Added To Partnership
Longtime partners Alvotech and Fuji Pharma – the latter being a minority shareholder in the Icelandic firm – have extended their existing biosimilars partnership in Japan, as Alvotech continues to make strategic moves across the globe.
